These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

66 related items for PubMed ID: 6127726

  • 21. [The beta-adrenolytic activity of new arylmethyloxypropanolamine analogs of dioxadilol].
    Baziard-Mouysset G, Ane-Margail M, Stigliani JL, Payard M, Verscheure Y, Tisne-Versailles J.
    J Pharm Belg; 1994; 49(2):126-32. PubMed ID: 7913492
    [Abstract] [Full Text] [Related]

  • 22. [Esmolol in anesthesiology: pharmacology and indications].
    Fita G, Gomar C, Rovira I.
    Rev Esp Anestesiol Reanim; 1999 Nov; 46(9):404-14. PubMed ID: 10613078
    [Abstract] [Full Text] [Related]

  • 23. Effect of bevantolol and propranolol on serum lipids in patients with essential hypertension.
    Sasaki J, Kajiyama G, Kusukawa R, Mori H, Koga S, Takagi R, Tanaka N, Ogawa N, Arakawa K.
    Int J Clin Pharmacol Ther; 1994 Dec; 32(12):660-4. PubMed ID: 7881705
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [The cardiovascular effects of the optical isomers of 1-(0-methoxy-phenoxy-)-3-isopropylamino-2-propanolo-hydrochloride (moprolol)].
    Merlo L, Brusoni B, Mussini E, Ghirardi P.
    Boll Soc Ital Cardiol; 1980 Dec; 25(8):955-61. PubMed ID: 6116496
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Pharmacology of new beta-adrenergic receptor blocking drugs. II. Bronchopulmonary and cardiovascular effects of VUL 111 and trimepranol (author's transl)].
    Drímal J, Seginko J, Gibala P, Strízová K.
    Bratisl Lek Listy; 1978 Oct; 70(4):429-39. PubMed ID: 31233
    [No Abstract] [Full Text] [Related]

  • 28. Does esmolol block the cardiovascular response to intubation?
    James RH.
    Anaesthesia; 1997 Nov; 52(11):1119. PubMed ID: 9404186
    [No Abstract] [Full Text] [Related]

  • 29. [Cholestatic hepatosis caused by Talinolol (Cordanum)?].
    Wiese M, Metzner C, Brunner HP, Klemm HP.
    Z Gesamte Inn Med; 1979 Jan 15; 34(2):86-8. PubMed ID: 34271
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Mechanism of action of the new beta-adrenolytic drug VUL 111 upon the cardiovascular system. 1. Beta-adrenolytic activity on peroral administration and ways of metabolic degradation (author's transl)].
    Drimal J, Strízová K, Borovicová F, Gibala P, Stefek M, Kovácik V.
    Bratisl Lek Listy; 1978 Jul 15; 70(1):11-28. PubMed ID: 28818
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Stereospecificity of beta-blocker effects on the glaucomatous eye].
    Krieglstein GK, Schrems W.
    Fortschr Ophthalmol; 1984 Jul 15; 81(2):127-9. PubMed ID: 6145665
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.